Clinical Trials Browser

Phase 3 × OTHER_GOV × Lymphoma, Large B-Cell, Diffuse × Clear all

NCT05164770 2021-12-21

Study of Zanubrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

Phase 3 Unknown

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT05097443 2021-11-19

Orelabrutinib, Rituximab and Combination Chemotherapy in Newly-diagnosed Aggressive B-cell Non-Hodgkin Lymphoma

Phase 3 Unknown

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell